Empirical antibiotic treatment of patients with acute myelogenous leukaemia;Empirisk antibiotikabehandling hos pasienter med akutt myelogen leukemi

Tidsskrift for den Norske Laegeforening

Volumn 119, Issue 1, 1999, Pages 35-38

  Tangen, Jon Magnus ^a   Berentsen, Sigbjørn ^b,e   Dahl, Inger Marie ^c   Ly, Bernt ^d   Myrvang, Bjørn ^a  

^a Medisinsk klinikk   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c Haraldsplass Diakonale Sykehus   (Norway)

^d AKER UNIVERSITY HOSPITAL   (Norway)

^e Medisinsk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; NETILMICIN; NYSTATIN; PENICILLIN G; TOBRAMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; FEVER; HUMAN; MAJOR CLINICAL STUDY; NORWAY;

ADOLESCENT; ADULT; AGED; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; EVALUATION STUDIES; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MIDDLE AGED; NEUTROPENIA; PENICILLIN G; PENICILLINS; RETROSPECTIVE STUDIES; SEPSIS;

EID: 0033540308     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Gale RP. Progress in acute myelogenous leukemia. Ann Intern Med 1984; 101: 702-5.
2. Rowe JM, Kiesveld JL. Treatment and prognostic factors in acute myelgenous leukemia. Baillcrcs Clin Haematol 1996; 9: 87-128.
3. Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 1995; 332: 217-23.
4. Bodey G, Bolivar R Fainstein V. Infectious complications in leukemic patients. Semin Hematol 1982; 19: 193-226.
5. O'Hanley P, Easaw J, Rugo H, Easaw S. Infectious disease management of adult leukemic patients undergoing-chemotherapy: 1982-1986 experience at Stanford University Hospital. Am J Med 1989; 87: 605-13.
6. Pizzo P. Management of fever in patients with cancer and treatment induced neutropenia. N Engl J Med 1993; 328: 1323-32.
7. Wade JC, Schimpff SC, Norman KA, Fortner CL, Standiford HC, Wiernicke PH. Piperacillin or tiarcillin plus amikacin. A double blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic patients. Am J Med 1981; 71: 983-90.
8. Bodey GP, Middleman E, Umsawadi T, Rodrigties V. Infections in cancer patients. Results with gentamycine therapy. Cancer 1972; 29: 1967-71.
9. Klastersky J, Cappel R, Daneau D. Clinical significance of in vitro synergism between antibiotics in gram negative infections. Antimicrob Agents Chemother 1972; 2: 470-5.
10. Rubin M, Pizzo P. Monotherapy for empirical management for febrile neutropenic patients. National Cancer Institute monographs 1990; 9: 111-6.
11. Haug JB, Hartug S, Kalger T, Digranes A, Solberg CO. Bloodstream infections at a norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features and outcome. Clin Infect Dis 1994; 9: 246-56.
12. Digranes A, Solberg CA, Sjursen H, Skovlund E, Sander J. Antibiotic susceptibility of blood culture isolates of Enterobacteriacea from six Norwegian hospitals 1991-1992. APMIS 1997; 105: 854-60.
13. Tangen J-M, Abdelnoor M, Brinch L, Dahl IM, Lamvik J, Ly B et al. Survival in 86 patients, aged 15-60, with primary acute myelogenous leukemia, treated in the Norwegian Health Regions I, III, IV and V in the period 1990-1995. Eur J Haematol 1997; 59: 110-4.
14. Immunocompromised Host Society. The design, analysis and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient: report of a consensus panel for the Immunocompromised Host Society. J Infect Dis 1990; 161: 397-401.
15. De Pauw B, Deresinski SC, Feld R, Lane-Allman EF, Donelly P. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. Ann Intern Med 1994; 120: 834-44.
16. Huijgens PC, Ossenkoppele GJ, Weijers TF, van Loenen AC, Simoons-Smit AM, Wijermans PW et al. Imipenemcilastin for empirical therapy in neutropenic patients with fever: An open study in hematologic malignancies. Eur J Haematol 1991; 46: 42-6.
17. Gregory L, Williams R, Thompson E. Leucocyte function in Down's syndrome and acute leukemia. Lancet 1972; 1: 1359-61.